Koyfin Home > Directory > Health Care > Amgen Inc > Total Equity

Amgen Inc Total Equity Chart (AMGN)

Amgen Inc annual/quarterly Total Equity from 2010 to 2020.
  • Amgen Inc Total Equity for the quarter ending September 09, 2020 was $10,959m a 11.73% increase of 1,286m year over year
  • Amgen Inc Total Equity for the last 12 months ending September 09, 2020 was $10,959m a 11.73% increase of 1,286m year over year
  • Amgen Inc Annual Total Equity for 2019 was $9,673m a -29.23% decrease of -2,827m from 2018
  • Amgen Inc Annual Total Equity for 2018 was $12,500m a -101.93% decrease of -12,741m from 2017
  • Amgen Inc Annual Total Equity for 2017 was $25,241m a -18.36% decrease of -4,634m from 2016
Other Balance Sheet Metrics:
  • Amgen Inc Total Assets for the quarter ending December 12, 2018 was $66,416m a -7.15% decrease of -4,748m year over year
  • Amgen Inc Other Liabilities for the quarter ending December 12, 2018 was $10,918m a -7.23% decrease of -789m year over year
View Chart On Koyfin

Quarterly AMGN Total Equity Data

09/2020$10,959m
06/2020$10,659m
03/2020$9,485m
12/2019$9,673m
09/2019$10,927m
06/2019$10,794m
03/2019$10,832m
12/2018$12,500m
09/2018$14,349m
06/2018$14,909m

Annual AMGN Total Equity Data

2019$9,673m
2018$12,500m
2017$25,241m
2016$29,875m
2015$28,083m
2014$25,778m
2013$22,096m
2012$19,060m
2011$19,029m
2010$23,944m